Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mannkind Corp (NASDAQ:MNKD)

3.92
Delayed Data
As of Aug 28
 +0.01 / +0.26%
Today’s Change
3.25
Today|||52-Week Range
7.88
-24.83%
Year-to-Date

Today’s Trading

Previous close3.91
Today’s open3.86
Day’s range3.77 - 3.92
Volume3,692,501
Average volume (3 months)7,038,649
Market cap$1.6B
Dividend yield--
Data as of 08/28/2015

Growth & Valuation

Earnings growth (last year)+20.31%
Earnings growth (this year)+43.42%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
THRXTheravance Inc0.000.00%
IRWDIronwood Pharmaceuti...+0.22+1.99%
TTPHTetraphase Pharmaceu...+3.48+8.59%
INSMInsmed Inc+0.56+2.23%
Data as of 08/28/2015

Financials

Next reporting dateNovember 2, 2015
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$198.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hakan S. Edstrom
Chief Operating Officer &
Chief Technology Officer
Juergen A. Martens
Corporate headquarters
Valencia, California

Forecasts

Partner Offers